Hormone replacement therapy and peripheral vascular disease in women

Vascular and Endovascular Surgery

Volumn 38, Issue 6, 2004, Pages 547-556

  Nguyen, Liz ^a   Liles, Debra R ^a   Lin, Peter H ^a   Bush, Ruth L ^a,b  

^a Houston VAMC 2002 ^*

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PLACEBO;

ABDOMINAL AORTA ANEURYSM; ARTERY DISEASE; ATHEROGENESIS; BLOOD CLOTTING; BLOOD VESSEL SHUNT; BREAST CARCINOMA; CAROTID ARTERY DISEASE; CLINICAL TRIAL; CYTOKINE PRODUCTION; ESTROGEN DEFICIENCY; EVIDENCE BASED MEDICINE; FEMALE; HEART PROTECTION; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; INTERMITTENT CLAUDICATION; LIFE EXPECTANCY; MENOPAUSAL SYNDROME; MENOPAUSE; MULTIVARIATE ANALYSIS; PATHOGENESIS; PERIPHERAL VASCULAR DISEASE; PREVENTIVE MEDICINE; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; STROKE; SYSTEMATIC REVIEW; THROMBOSIS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

AORTIC ANEURYSM, ABDOMINAL; ARTERIOSCLEROSIS; CAROTID ARTERY DISEASES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; PERIPHERAL VASCULAR DISEASES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 10344230930     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/153857440403800609     Document Type: Review

References (60)

1. Eaker ED, Chesebro JH, Sacks FM, et al: Cardiovascular disease in women. Circulation 88(4 Pt 1):1999-2009, 1993.
2. Higgins JP, Higgins JA: Epidemiology of peripheral arterial disease in women. J Epidemiol 13:1-14, 2003.
3. Eugster T, Gurke L, Obeid T, et al: Infrainguinal arterial reconstruction: Female gender as risk factor for outcome. Eur J Vasc Endovasc Surg 24:245-248, 2002.
4. Enzler MA, Ruoss M, Seifert B, et al: The influence of gender on the outcome of arterial procedures in the lower extremity. Eur J Vasc Endovasc Surg 11:446-452, 1996.
5. Marrugat J, Sala J, Masia R, et al: Mortality differences between men and women following first myocardial infarction. RESCATE Investigators. Recursos Empleados en el Sindrome Coronario Agudo y Tiempo de Espera. JAMA 280:1405-1409, 1998.
6. Khan SS, Nessim S, Gray R, et al: Increased mortality of women in coronary artery bypass surgery: Evidence for referral bias. Ann Intern Med 112:561-567, 1990.
7. Writing Group for the Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled study. JAMA 288:321-333, 2002.
8. Diehm C, Schuster A, Allenberg JR, et al: High prevalence of peripheral arterial disease and co-morbidity in 6,880 primary care patients: Cross-sectional study. Atherosclerosis 172:95-105, 2004.
9. Lane JS, Shekherdimian S, Moore WS: Does female gender or hormone replacement therapy affect early or late outcome after carotid endarterectomy? J Vasc Surg 37:568-574, 2003.
10. Magnant JG, Cronenwett JL, Walsh DB, et al: Surgical treatment of infrainguinal arterial occlusive disease in women. J Vasc Surg 17:67-76; discussion 76-78, 1993.
11. Katz DJ, Stanley JC, Zelenock GB: Gender differences in abdominal aortic aneurysm prevalence, treatment, and outcome. J Vasc Surg 25:561-568, 1997.
12. Sarac TP, Hertzer NR, Mascha EJ, et al: Gender as a primary predictor of outcome after carotid endarterectomy. J Vasc Surg 35:748-753, 2002.
13. Ballotta E, Renon L, Da Giau G, et al: Carotid endarterectomy in women: Early and long-term results. Surgery 127:264-271, 2000.
14. McDermott MM, Greenland P, Liu K, et al: The ankle brachial index is associated with leg function and physical activity: The Walking and Leg Circulation Study. Ann Intern Med 136:873-883, 2002.
15. Amighi J, Sabeti S, Schlager O, et al: Outcome of conservative therapy of patients with severe intermittent claudication. Eur J Vasc Endovasc Surg 27:254-258, 2004.
16. Cheanvechai V, Harthun NL, Graham LM, et al: Incidence of peripheral vascular disease in women: Is it different from that in men? Thorac Cardiovasc Surg 127:314-317, 2004.
17. Lindner V, Kim SK, Karas RH, et al: Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury. Circ Res 83:224-229, 1998.
18. Karas RH, Patterson BL, Mendelsohn ME: Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 89:1943-1950, 1994.
19. Caulin-Glaser T, Watson CA, Pardi R, et al: Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest 98:36-42, 1996.
20. Pacifici R, Brown C, Puscheck E, et al: Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 88:5134-5138, 1991.
21. Berg G, Ekerfelt C, Hammar M, et al: Cytokine changes in postmenopausal women treated with estrogens: A placebo-controlled study. Am J Reprod Immunol 48:63-69, 2002.
22. Anwar A, Zahid AA, Scheidegger KJ, et al: Tumor necrosis factor-alpha regulates insulin-like growth factor-1 and insulin-like growth factor binding protein-3 expression in vascular smooth muscle. Circulation 105:1220-1225, 2002.
23. DeGraba TJ: Expression of inflammatory mediators and adhesion molecules in human atherosclerotic plaque. Neurology 49(5 suppl 4):S15-S19, 1997.
24. Pradhan AD, Manson JE, Rossouw JE, et al: Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: Prospective analysis from the Women's Health Initiative observational study. JAMA 288:980-987, 2002.
25. Walsh BW, Schiff I, Rosner B, et al: Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325:1196-1204, 1991.
26. Nabulsi AA, Folsom AR, Szklo M, et al: No association of menopause and hormone replacement therapy with carotid artery intima-media thickness. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 94:1857-1863, 1996.
27. Koivu TA, Dastidar P, Jokela H, et al: The relation of oxidized LDL autoantibodies and long-term hormone replacement therapy to ultrasonographically assessed atherosclerotic plaque quantity and severity in postmenopausal women. Atherosclerosis 157:471-479, 2001.
28. Hashimoto K, Nozaki M, Nakano H: Positive effects of conjugated equine estrogen on triglyceride metabolism in oophorectomized women based on a stratification analysis of pretreatment values. Fertil Steril 81:1041-1046, 2004.
29. Lamon-Fava S, Posfai B, Asztalos BF, et al: Effects of estrogen and medroxyprogesterone acetate on subpopulations of triglyceride-rich lipoproteins and high-density lipoproteins. Metabolism 52:1330-1336, 2003.
30. Herrington DM, Reboussin DM, Brosnihan KB, et al: Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 343: 522-529, 2000.
31. Scarabin PY, Plu-Bureau G, Bara L, et al: Haemostatic variables and menopausal status: Influence of hormone replacement therapy. Thromb Haemost 70: 584-587, 1993.
32. Post MS, van der Mooren MJ, van Baal WM, et al: Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: A randomized placebo-controlled study. Am J Obstet Gynecol 189:1221-1227, 2003.
33. Oger E, Alhenc-Gelas M, Lacut K, et al, and the SARAH Investigators: Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: A randomized trial. Arterioscler Thromb Vasc Biol 23:1671-1676; Epub July 17, 2003.
34. Post MS, Rosing J, Van Der Mooren MJ, et al: Ageing Women and the Institute for Cardiovascular Research-Vrije Universiteit (ICaR-VU). Increased resistance to activated protein C after short-term oral hormone replacement therapy in healthy postmenopausal women. Br J Haematol 119:1017-1023, 2002.
35. Grady D, Herrington D, Bittner V, et al, and the HERS Research Group: Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow-up (HERS II). JAMA 288:49-57, 2002.
36. Hulley S, Grady D, Bush T, et al: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 280:605-613, 1998.
37. Rosendaal FR, Vessey M, Rumley A, et al: Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis. Br J Haematol 116:851-854, 2002.
38. Rossouw JE: Hormones, genetic factors, and gender differences in cardiovascular disease. Cardiovasc Res 53:550-557, 2002.
39. Grodstein F, Manson JE, Stampfer MJ: Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study: A prospective, observational study. Ann Intern Med 135:1-8, 2001.
40. Nathan L, Pervin S, Singh R, et al: Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo: Possible mechanisms for gender differences in atherosclerosis. Circ Res 85:377-385, 1999.
41. Stampfer MJ, Colditz GA, Willett WC, et al: Postmenopausal estrogen therapy and cardiovascular disease: Ten-year follow-up from the Nurses' Health Study. N Engl J Med 325:756-762, 1991.
42. Barrett-Connor E, Grady D: Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health 19:55-72, 1998.
43. Hemminki E, McPherson K: Impact of postmenopausal hormone therapy on cardiovascular events and cancer: Pooled data from clinical trials. BMJ 315:149-153, 1997.
44. Westendorp IC, in't Veld BA, Grobbee DE, et al: Hormone replacement therapy and peripheral arterial disease: The Rotterdam study. Arch Intern Med 160: 2498-2502, 2000.
45. Anderson GL, Limacher M, Assaf AR, et al: Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. JAMA 291:1701-1712, 2004.
46. Hsia J, Criqui MH, Rodabough RJ, et al, and the Women's Health Initiative Investigators: Estrogen plus progestin and the risk of peripheral arterial disease: The Women's Health Initiative. Circulation 109:620-626, 2004.
47. Lutldn EG, Wahner HW, O'Fallon WM, et al: Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 117:1-9, 1992.
48. Angerer P, Stork S, Kothny W, et al: Effect of oral postmenopausal hormone replacement on progression of atherosclerosis: A randomized, controlled trial. Arteriosder Thromb Vasc Biol 21:262-268, 2001.
49. Angerer P, Kothny W, Stork S, et al: Hormone replacement therapy and distensibility of carotid arteries in postmenopausal women: A randomized, controlled trial. J Am Coll Cardiol 36:1789-1796, 2000.
50. Byington RP, Furberg CD, Herrington DM, et al: Heart and Estrogen/Progestin Replacement Study Research Group. Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease: HERS B-mode substudy. Arterioscler Thromb Vasc Biol 22:1692-1697, 2002.
51. Nabulsi AA, Folsom AR, White A, et al: Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. N Engl J Med 328:1069-1075, 1993.
52. Angerer P, Stork S, Kothny W, et al: Effect of postmenopausal hormone replacement on atherosclerosis in femoral arteries. Maturitas 41:51-60, 2002.
53. Hodis HN, Mack WJ, Lobo RA, et al, and the Estrogen in the Prevention of Atherosclerosis Trial Research Group: Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 135:939-953, 2001.
54. Le Gal G, Gourlet V, Hogrel P, et al: Hormone replacement therapy use is associated with a lower occurrence of carotid atherosclerotic plaques but not with intima-media thickness progression among postmenopausal women. The vascular aging (EVA) study. Atherosclerosis 166:163-170, 2003.
55. Schneider JR, Droste JS, Golan JF: Carotid endarterectomy in women versus men: Patient characteristics and outcomes. J Vasc Surg 25:890-896; discussion 897-898, 1997.
56. Hertzer NR, O'Hara PJ, Mascha EJ, et al: Early outcome assessment for 2,228 consecutive carotid endarterectomy procedures: The Cleveland Clinic experience from 1989 to 1995. J Vasc Surg 26:1-10, 1997.
57. Maxwell JG, Rutledge R, Covington DL, et al: A statewide, hospital-based analysis of frequency and outcomes in carotid endarterectomy. Am J Surg 174:655-660; discussion 660-661, 1997.
58. Ozsvath KJ, Darling RC, Tabatabai L, et al: Carotid endarterectomy in the elderly: Does gender effect outcome? Cardiovasc Surg 10:534-537, 2002.
59. Ballotta E, Renon L, Da Giau G, et al: Carotid endarterectomy in women: Early and long-term results. Surgery 127:264-271, 2000.
60. Mattos MA, Sumner DS, Bohannon WT, et al: Carotid endarterectomy in women: Challenging the results from ACAS and NASCET. Ann Surg 234:438-445; discussion 445-446, 2001.